by Mike Regan | Dec 31, 2024 | News
Excelsior Equities is terminating coverage of the cannabis sector due to reallocation of resources. While we remain bullish on the secular trends and fundamentals of the legal cannabis sector, and we remain bullish on select operators with better balance sheets and...
by Mike Regan | Oct 21, 2024 | News
Mike Regan, Director of Research at Excelsior Equities, has published an initiation report on High Tide (HITI/HITI.V, $2.71/C$3.73), “Specialty Retailer with 62% Store Growth, Widening Competitive Moat, and 26% Upside to Comp Multiple” with a BUY rating...
by Mike Regan | Feb 7, 2024 | News
Mike Regan, Director of Research at Excelsior Equities, has published an initiation report on Glass House Brands (GLASF/GLAS.NE, $6.80/$6.80), “Low-Cost High-Quality Producer Expanding Production & Profits, Cash Flow & Balance Sheet Benefits from...
by Mike Regan | Jan 29, 2024 | News
Mike Regan, Director of Research at Excelsior Equities, has published an initiation report on Trulieve Cannabis Corp (TCNNF/TRUL.CN, $8.67/C$11.71), “Undervalued on Status Quo + FCF & Upside Regulatory Catalysts: Rescheduling, Florida and Pennsylvania Adult...
by Mike Regan | Oct 30, 2023 | News
Mike Regan, Director of Research at Excelsior Equities, has published an initiation report on Verano Holdings (VRNOF/VRNO.NE, $3.25/C4.36), “Free Cash Flow, Growth Opportunities, Strong Balance Sheet, Potential Adult Use in Ohio, Florida and Pennsylvania”...
